Section 3: Production and Compounding

3PC-002

PRELIMINARY RESULTS ON THE USE OF ORAL REHYDRATION SOLUTION IN THE FORM OF GELATO FOR REHYDRATION OF CHILDREN WITH ACUTE GASTROENTERITIS

3PC-001

MAGISTRAL FORMULATION OF 10% SUCRALFATE ENEMAS IN PROCTITIS

3PC-037

CLEANING VALIDATION OF SOLUTION PRODUCTION IN A HOSPITAL PHARMACY

3PC-039

CENTRALISED NON-HAZARDOUS INTRAVENOUS COMPOUNDING: IMPROVEMENT OF CLINICAL PRACTICE

3PC-035

SO, HAPPY? AUTOMATED NOMINATIVE DISPENSATION: SATISFACTION SURVEY OF THE NURSING STAFF

3PC-034

SCREENING FOR PHYSICOCHEMICAL INCOMPATIBILITIES OF CYTOTOXIC DRUGS AFTER RECONSTITUTION: THE CASE OF METHOTREXATE

3PC-033

IN VITRO PHYSICOCHEMICAL INTERACTIONS STUDY BETWEEN IRON AND ANTICANCER DRUGS ADMINISTRATED IN HOSPITAL

3PC-027

AMIFAMPRIDINE AND PYRIDOSTIGMINE HARD CAPSULES FOR TREATMENT OF CONGENITAL MYASTHENIC SYNDROMES: A CASE REPORT

3PC-026

PHYSICOCHEMICAL STABILITY OF ROCURONIUM BROMIDE INJECTION SOLUTION 10 MG/ML AS BULK SOLUTION AND IN 10 ML READY-TO-ADMINISTER SYRINGES

3PC-015

MEDIA-FILL SIMULATION TESTS OF INFUSION BAGS PREPARED IN SERIES BY THE COMPOUNDING ROBOT APOTECACHEMO

3PC-012

STABILITY OF CEFUROXIME 80 MG/ML SOLUTION IN READY-TO-ADMINISTER POLYPROPYLENE SYRINGES

3PC-009

PHYSICOCHEMICAL STABILITY OF INTRAVENOUS INJECTION OF A GENERIC PRODUCT OF FUROSEMIDE PREPARED IN POLYPROPYLENE SYRINGES

3PC-008

FORMULATION AND STABILITY STUDY OF THE EXTEMPORANEOUS ORAL SOLUTIONS OF CARDIOLOGIC DRUGS FOR PERSONALISED THERAPY OF NEWBORNS

3PC-003

PAEDIATRIC PARENTERAL NUTRITION ON WEEKENDS: WHO PREPARES? SURVEY OF COUNTRY’S HOSPITALS

3PC-017

TIME SAVINGS AND IMPROVED QUALITY ASSURANCE OF INTRAVENOUS CYTOSTATICS WITH SEMIAUTOMATED DOSE-BANDING

Pages